MANKIND PHARMA
Back to Income Statement
|
MANKIND PHARMA Last 5 Year Total Expenditure History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹10,655 Cr | ₹9,187 Cr | ₹7,745 Cr | ₹6,848 Cr | ₹5,791 Cr |
What is the latest Total Expenditure of MANKIND PHARMA ?
| Year | Total Expenditure |
|---|---|
| Mar2026 | ₹10,655 Cr |
| Mar2025 | ₹9,187 Cr |
| Mar2024 | ₹7,745 Cr |
| Mar2023 | ₹6,848 Cr |
| Mar2022 | ₹5,791 Cr |
How is Total Expenditure of MANKIND PHARMA Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2026 | ₹10,655 Cr | 15.98 | |
| Mar2025 | ₹9,187 Cr | 18.61 | |
| Mar2024 | ₹7,745 Cr | 13.11 | |
| Mar2023 | ₹6,848 Cr | 18.24 | |
| Mar2022 | ₹5,791 Cr | - | |
Compare Total Expenditure of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹105,608.2 Cr | 2.6% | 1.1% | -3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,842.0 Cr | 1.1% | 4.6% | 14.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,860.0 Cr | 0.6% | 8.3% | 8.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹192,687.0 Cr | 6.3% | 12.2% | 45.5% | Stock Analytics | |
| CIPLA | ₹112,593.0 Cr | -1.7% | -2.8% | -4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,364.9 Cr | -3.7% | -10.4% | -6% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 2.6% |
1.1% |
-3% |
| SENSEX | -1% |
-0.9% |
-7.5% |
You may also like the below Video Courses